← back to search

Fredrik Nyberg

National Academy of Medicine ·
Area of research
Infectious Diseases · Health, Toxicology and Mutagenesis
Research interest
Research interests include COVID-19 Clinical Research Studies, Air Quality and Health Impacts, Chronic Obstructive Pulmonary Disease (COPD) Research, and SARS-CoV-2 and COVID-19 Research.
h-index
67
citations
20,190
works
418
NIH funding
primary concept
email

Recent publications

Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study
EClinicalMedicine 2023cited by 25position: middledoi
Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe
Wellcome Open Research 2023cited by 4position: middledoi
Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network
BMC Medical Research Methodology 2022cited by 33position: middledoi
Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS
Clinical Epidemiology 2022cited by 26position: middledoi
Uncontrolled asthma predicts severe COVID-19: a report from the Swedish National Airway Register
Therapeutic Advances in Respiratory Disease 2022cited by 17position: middledoi
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study
BMJ 2021cited by 71position: middledoi
Swedish Covid-19 Investigation for Future Insights – A Population Epidemiology Approach Using Register Linkage (SCIFI-PEARL)
Clinical Epidemiology 2021cited by 67position: firstdoi
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries
Lara D. Veeken 2021cited by 53position: middledoi
Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience
PEDIATRICS 2021cited by 49position: middledoi
Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study
JMIR Medical Informatics 2021cited by 26position: middledoi
Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom
International Journal of Obesity 2021cited by 23position: middledoi
Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study
BMJ Open 2021cited by 15position: middledoi
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
The Lancet Rheumatology 2020cited by 153position: middledoi
Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
The Lancet Digital Health 2020cited by 128position: middledoi
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
Nature Communications 2020cited by 107position: middledoi
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study
Lara D. Veeken 2020cited by 47position: middledoi
Characteristics and outcomes of 627 044 COVID-19 patients with and without obesity in the United States, Spain, and the United Kingdom
medRxiv 2020cited by 6position: middledoi
Prospective observational study in patients with obstructive lung disease: NOVELTY design
ERJ Open Research 2019cited by 51position: middledoi
Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study
Clinical Rheumatology 2018cited by 31position: middledoi
Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme
RMD Open 2017cited by 29position: lastdoi
S2k guideline for treatment of cutaneous lupus erythematosus – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)
Journal of the European Academy of Dermatology and Venereology 2016cited by 188position: middledoi
Meta-analysis of genome-wide association studies of HDL cholesterol response to statins
Journal of Medical Genetics 2016cited by 37position: middledoi
Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease
Annals of the Rheumatic Diseases 2016cited by 25position: middledoi
Risk Factors for the Rapid Increase in Risk of Acute Coronary Events in Patients With New‐Onset Rheumatoid Arthritis: A Nested Case–Control Study
Arthritis & Rheumatology 2015cited by 57position: middledoi
How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries
Annals of the Rheumatic Diseases 2015cited by 28position: middledoi
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
Nature Communications 2014cited by 278position: middledoi
Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the <scp>EUSCLE</scp> database
British Journal of Dermatology 2014cited by 78position: middledoi
Genome-wide Association Analysis of Blood-Pressure Traits in African-Ancestry Individuals Reveals Common Associated Genes in African and Non-African Populations
The American Journal of Human Genetics 2013cited by 233position: middledoi
Novel childhood asthma genes interact with in utero and early-life tobacco smoke exposure
Journal of Allergy and Clinical Immunology 2013cited by 51position: middledoi
Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden
British Journal of Dermatology 2012cited by 139position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Jeffrey D. Greenberg · Bentley University4 papers (2015–2018)Johan Askling · Karolinska University Hospital4 papers (2015–2017)Thomas Frisell · Karolinska Institutet4 papers (2015–2017)Dimitrios A. Pappas · University of Alabama at Birmingham4 papers (2015–2018)Marie Holmqvist · Karolinska University Hospital4 papers (2015–2017)George Reed · University of Massachusetts Chan Medical School4 papers (2015–2018) · 4 papers (2015–2021) · 4 papers (2015–2018) · 4 papers (2015–2018) · 3 papers (2015–2017)Suzanne Verstappen · University of Manchester3 papers (2015–2017) · 3 papers (2015–2017)Deborah Symmons · University of Manchester3 papers (2015–2017) · 3 papers (2015–2017)Kaleb Michaud · University of Kansas3 papers (2015–2017) · 3 papers (2015–2017)Hisashi Yamanaka · Sanno Medical Center3 papers (2015–2017) · 3 papers (2015–2017) · 2 papers (2016–2017)Lowie E.G.W. Vanfleteren · Lund University2 papers (2021–2022)